Related Experiment Videos

Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV

P S Moore1, Y Chang

  • 1Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. psm9@columbia.edu

Insights

Many tumor viruses use oncogenes to inhibit cellular tumor-suppressor pathways. Kaposi-sarcoma-associated herpesvirus (KSHV) also hijacks cellular genes, suggesting these pathways are a key defense against viral infections.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Tumor viruses often encode oncogenes that disrupt cellular tumor-suppressor pathways.
  • The evolutionary reasons for independent oncogene acquisition by diverse viruses remain unclear.
  • Kaposi-sarcoma-associated herpesvirus (KSHV, or HHV8) is known to acquire cellular genes crucial for cell survival and proliferation.

Purpose of the Study:

  • To review the functions of KSHV-pirated genes.
  • To compare the cellular pathways targeted by KSHV with those targeted by other tumor viruses.
  • To explore the role of tumor-suppressor pathways in antiviral defense.

Main Methods:

  • Literature review of KSHV oncogenes and their cellular targets.
  • Comparative analysis of viral oncogene activities across different virus families.
  • Synthesis of current knowledge on viral hijacking of tumor-suppressor pathways.

Main Results:

  • KSHV pirated cellular genes encode proteins with diverse functions.
  • Many KSHV-encoded proteins target the same cellular pathways as oncogenes from unrelated tumor viruses.
  • These shared targets include key regulators of cell survival and proliferation.

Conclusions:

  • The convergent evolution of oncogenes targeting similar cellular pathways suggests a conserved viral strategy.
  • Tumor-suppressor pathways may serve a dual role: regulating cell proliferation and acting as a primary defense against persistent viral infections.
  • Understanding these viral-cellular interactions is crucial for developing novel antiviral and anticancer therapies.

Related Concept Videos